Rapt Therapeutics, Inc. (RAPT)
57.76
-0.01
(-0.02%)
USD |
NASDAQ |
Feb 10, 15:53
Rapt Therapeutics EPS Diluted (Quarterly) : -0.652 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Penumbra, Inc. | 1.167 |
| Boston Scientific Corp. | 0.4493 |
| Johnson & Johnson | 2.098 |
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.58M |
| Total Expenses (Quarterly) | 17.58M |
| Enterprise Value | 800.64M |
| Earnings Yield | -18.20% |
| Normalized Earnings Yield | -18.20 |